{
    "2020-10-06": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Hedge Funds Have Never Been Less Bullish On Novartis AG (NVS)",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Less Bullish",
                        "Novartis AG"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "GlycoMimetics' Rivipansel Gets Rare Pediatric Disease Status",
                "features": {
                    "keywords": [
                        "GlycoMimetics",
                        "Rivipansel",
                        "Rare Pediatric Disease Status"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}